Matthew Kurtz, PhD
About
Education & Training
- PhD
- Princeton University (1995)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Matthew Kurtz's published research.
Michal Assaf, MD
Morris Bell, PhD, ABPP
Silvia Corbera, PhD
Publications
2025
International perspective on social cognition in schizophrenia: current stage and the next steps
Corbera S, Kurtz M, Achim A, Agostoni G, Amado I, Assaf M, Barlati S, Bechi M, Cavallaro R, Ikezawa S, Okano H, Okubo R, Penadés R, Uchino T, Vita A, Yamada Y, Bell M. International perspective on social cognition in schizophrenia: current stage and the next steps. European Psychiatry 2025, 68: e9. PMID: 39812093, PMCID: PMC11795453, DOI: 10.1192/j.eurpsy.2024.1776.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsSocial cognitionSocial neuroscienceAssess social cognitionSocial cognitive measuresSocial cognitive abilitiesClinical psychologyCognitive measuresSocial dysfunctionCognitive abilitiesSchizophreniaCognitive evaluationFunctional difficultiesCognitionCognitive scienceClinical practiceNeuroscienceMounting evidenceInternational scientific researchPsychologyCliniciansPsychiatryPoor clinical outcomesScientific rigorIllnessResearch
2024
The Effects of Cognitive Remediation on Negative Symptoms in Schizophrenia-Spectrum Illness: A Meta-analytic Investigation of Efficacy
Melville G, Preisig C, Zheng M, Kurtz M. The Effects of Cognitive Remediation on Negative Symptoms in Schizophrenia-Spectrum Illness: A Meta-analytic Investigation of Efficacy. Schizophrenia Bulletin 2024, sbae185. PMID: 39485015, DOI: 10.1093/schbul/sbae185.Peer-Reviewed Original ResearchConceptsNegative symptomsCognitive remediationEffects of cognitive remediationTrials of cognitive remediationSchizophrenia spectrum illnessEffect size improvementsMeta-analytic investigationCR effectsDuration of illnessPrograms of CRSmall-to-moderate improvementsAntipsychotic dosageEffects of CRSchizophrenia spectrumImprove cognitive skillsTreatment ingredientsModeration analysisBehavioral interventionsStrategy trainingCognitive skillsSize improvementsTask practiceInvestigation of efficacySchizophreniaSample differencesCognitive training for schizophrenia: Do race and ethnicity matter?
Gu B, Rose J, Kurtz M. Cognitive training for schizophrenia: Do race and ethnicity matter? Schizophrenia Research 2024, 272: 20-25. PMID: 39181007, PMCID: PMC11848525, DOI: 10.1016/j.schres.2024.08.009.Peer-Reviewed Original ResearchConceptsCognitive remediation treatmentCognitive trainingResponse to cognitive trainingEvidence-based psychosocial treatmentsTreatment drop-out ratesLevel of cognitive impairmentImpairment prior to treatmentRacial/ethnic minority statusCognitive remediationWorking memoryPsychosocial treatmentsCognitive deficitsDrop-out rateSymptom severityCognitive impairmentSchizophreniaSecondary analysis of dataRacial/ethnic minoritiesTreatment responseRacial/ethnic differencesMinority statusLevel of improvementCognitionMild to moderate improvementResearch literatureCognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence
Kurtz M. Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence. American Journal Of Psychiatry 2024, 181: 471-473. PMID: 38822589, DOI: 10.1176/appi.ajp.20240281.Peer-Reviewed Original ResearchDo metacognitive therapies for schizophrenia-spectrum disorders work? A meta-analytic investigation.
Melville G, Hoffman M, Pollock A, Kurtz M. Do metacognitive therapies for schizophrenia-spectrum disorders work? A meta-analytic investigation. Psychological Medicine 2024, 54: 1510-1518. PMID: 38509837, DOI: 10.1017/s0033291724000564.Peer-Reviewed Original ResearchConceptsSchizophrenia spectrum disordersMetacognitive therapyNegative symptomsSocial cognitionEfficacy of metacognitive therapyMeta-cognitive therapySingle-session interventionSmall-to-moderate effectsDuration of illnessAntipsychotic dosagePositive symptom outcomesPositive symptomsIllness insightPotential moderatorsPsychosocial functioningSymptom outcomesCognitive biasesSecondary symptomsControlled trialsClinical insightsSample differencesCognitionSmall effectsSymptomsDisorders